Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print June 2, 2008, 10.1097/PSY.0b013e3181772157
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Jarlais, D. C. D.
Right arrow Articles by Semaan, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarlais, D. C. D.
Right arrow Articles by Semaan, S.
Related Collections
Right arrow Reviews
Right arrow Substance Abuse
Right arrow HIV/AIDS
Psychosomatic Medicine 70:606-611 (2008)
© 2008 American Psychosomatic Society


TREATMENT AND PREVENTIVE INTERVENTIONS

HIV Prevention for Injecting Drug Users: The First 25 Years and Counting

Don C. Des Jarlais, PhD and Salaam Semaan, DrPH

From the Baron Edmond de Rothschild Chemical Dependency Institute (D.C.D.J.), Beth Israel Medical Center, New York, New York; and National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (S.S.), Centers for Disease Control and Prevention, Atlanta, Georgia.

Address correspondence and reprint requests to Don C. Des Jarlais, Beth Israel Medical Center/CDI, 160 Water Street—24th Floor, New York, NY 10038. E-mail: dcdesjarla{at}aol.com

During the last three decades, both the injection of illicit psychoactive drugs and HIV infection among injecting drug users (IDUs) have spread throughout industrialized and developing countries. Extremely rapid transmission of HIV has occurred in IDU populations with incidence rates of 10 to 50/100 person-years. In sharp contrast, there are many examples of very effective HIV risk reduction for IDUs, both in preventing initial epidemics and in bringing existing epidemics under control. IDUs are capable of learning basic information about HIV/AIDS and modifying their behavior to protect both themselves and their peers. Effective HIV prevention for IDUs requires programs that treat IDUs with dignity and respect, provide accurate information and the means for behavior change—access to sterile injection equipment, condoms, and drug abuse treatment. Programs that provide these services need to be implemented on a public health scale for IDU populations at risk for HIV infection.

Key Words: injecting drug use • HIV prevention • HIV/AIDS

Abbreviations: IDU = injecting drug user.




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
J. Leserman and L. R. Temoshok
A Road Well Traveled (Although Not Yet a Super Highway)
Psychosom Med, June 1, 2008; 70(5): 521 - 522.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
N. Klimas, A. O. Koneru, and M. A. Fletcher
Overview of HIV
Psychosom Med, June 1, 2008; 70(5): 523 - 530.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. J. Repetto and J. M. Petitto
Psychopharmacology in HIV-Infected Patients
Psychosom Med, June 1, 2008; 70(5): 585 - 592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Psychosomatic Society